Clearmind completes Part A of Phase I/II trial for alcohol disorder drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Clearmind completes Part A of Phase I/II trial for alcohol disorder drug
(NASDAQ: CMND) Delayed: 0.80 -0.06 (6.98%)
Previous Close $0.86    52 Week High $ 
Open $0.85    52 Week Low $ 
Day High $0.86    P/E N/A 
Day Low $0.77    EPS $ 
Volume 194,696